000912547 001__ 912547
000912547 005__ 20230816204234.0
000912547 0247_ $$2doi$$a10.1093/nop/npac059
000912547 0247_ $$2ISSN$$a2054-2577
000912547 0247_ $$2ISSN$$a2054-2585
000912547 0247_ $$2Handle$$a2128/33903
000912547 0247_ $$2pmid$$a36388412
000912547 0247_ $$2WOS$$aWOS:000885427200002
000912547 037__ $$aFZJ-2022-05720
000912547 082__ $$a610
000912547 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author
000912547 245__ $$aImaging patterns in patients with newly diagnosed glioblastoma in England
000912547 260__ $$aOxford$$bOxford Univ. Press$$c2022
000912547 3367_ $$2DRIVER$$aarticle
000912547 3367_ $$2DataCite$$aOutput Types/Journal article
000912547 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1692187424_26781
000912547 3367_ $$2BibTeX$$aARTICLE
000912547 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000912547 3367_ $$00$$2EndNote$$aJournal Article
000912547 520__ $$aThe study by Dumba and colleagues1 explored the incidence and timing of various peridiagnostic neuroimaging techniques such as MRI, CT, and PET in patients with newly diagnosed glioblastoma using a national database. Particularly, preoperative, early postoperative, and pre-radiotherapy imaging patterns for all glioblastoma patients aged 15–99 years resident in England in the years 2013 and 2014 were retrospectively evaluated.The entire cohort for data analysis comprised 4,307 patients. The main finding of the study is that prediagnostic imaging appears uniform, whereas postdiagnostic imaging practice varied considerably. Of note, the authors observed that there is clear evidence for low use of early postoperative MRI, the low use of additional MR imaging before radiotherapy, and the very limited use of other neuroimaging techniques such as advanced MRI and PET. For example, in the group of patients who underwent surgery and chemoradiation, only 51% had an early postoperative MRI within 72 hours after surgery. In patients undergoing surgery who subsequently received radiotherapy, only 61% had both an early postoperative and a pre-radiotherapy MRI. To improve the diagnostic performance, only 7% of the cohort underwent one or more of the advanced MRI options (ie, perfusion-weighted MRI, proton MR spectroscopy), and less than 1% of the cohort had additional PET imaging with various tracers (eg, radiolabeled amino acids, [18F]-2-fluoro-2-deoxy-D-glucose) during the course of the disease.
000912547 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000912547 588__ $$aDataset connected to DataCite
000912547 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b1
000912547 773__ $$0PERI:(DE-600)2768945-1$$a10.1093/nop/npac059$$gVol. 9, no. 6, p. 461 - 462$$n6$$p461 - 462$$tNeuro-oncology practice$$v9$$x2054-2577$$y2022
000912547 8564_ $$uhttps://juser.fz-juelich.de/record/912547/files/Galldiks_2022_Imaging%20patterns%20in%20patients%20with%20newly%20diagnosed%20glioblastoma%20in%20England.pdf$$yPublished on 2022-12-06. Available in OpenAccess from 2023-12-06.
000912547 909CO $$ooai:juser.fz-juelich.de:912547$$popen_access$$popenaire$$pdnbdelivery$$pdriver$$pVDB
000912547 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000912547 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b1$$kFZJ
000912547 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000912547 9141_ $$y2022
000912547 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-15
000912547 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-15
000912547 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000912547 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2022-11-15
000912547 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-15
000912547 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-15
000912547 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-15
000912547 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-06
000912547 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-15
000912547 920__ $$lyes
000912547 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000912547 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000912547 980__ $$ajournal
000912547 980__ $$aVDB
000912547 980__ $$aI:(DE-Juel1)INM-3-20090406
000912547 980__ $$aI:(DE-Juel1)INM-4-20090406
000912547 980__ $$aUNRESTRICTED
000912547 9801_ $$aFullTexts